EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation

Geoffrey D Barnes, Walter Ageno, Lana A Castellucci, Thita Chiasakul, Renee Eslick, José L Ferreiro, David Gailani, Diana A Gorog, Gregory Y H Lip, Leslie Raffini, Suely M Rezende, Jeffrey I Weitz und 1 weitere

Journal of Thrombosis and Haemostasis · 2023-05 · 21 (5) · 1381-1384

DOI: 10.1016/j.jtha.2023.02.008 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-05. Verfasst von Geoffrey D Barnes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: gbarnes@umich.edu. Hauptthemen laut MEDLINE: Thrombosis, Atrial Fibrillation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, University of Ottawa, Heart and Stroke Foundation of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral anticoagulation therapy has evolved beyond vitamin K antagonists to include oral direct thrombin inhibitors and factor Xa inhibitors. Collectively known as "direct oral anticoagulants," this class of medications represents the current standard of care for the prevention and treatment of common thrombotic disorders, including atrial fibrillation and venous thromboembolism. Medications that target factors XI/XIa and XII/XIIa are currently under investigation for several thrombotic and nonthrombotic conditions. Given that these emerging medications will likely have distinct risk-benefit profiles to the current direct oral anticoagulants, may have different routes of administration, and could be used for unique clinical conditions (e.g., hereditary angioedema), the International Society on Thrombosis and Haemostasis Subcommittee on Control of Anticoagulation assembled a writing group to make recommendations on the nomenclature of anticoagulant medications. With input from the broader thrombosis community, the writing group recommends that anticoagulant medications be described by the route of administration and specific targets (e.g., oral factor XIa inhibitor).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisAtrial FibrillationHumansAnticoagulantsAntithrombinsBlood CoagulationFactor Xa InhibitorsHemostasisAdministration, Oral

Stichwörter der Autor:innen

anticoagulantatrial fibrillationfactor XIIfactor XIafactor Xa inhibitorsvenous thromboembolism

Substanzen

AnticoagulantsAntithrombinsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: gbarnes@umich.edu.
  • Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada. Electronic address: https://twitter.com/LanaCastellucci.
  • Department of Medicine, Research Unit in Translational Hematology, Division of Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailan…
  • Department of Haematology, Canberra Health Services, Garran, Australia. Electronic address: https://twitter.com/Renee_Eslick.
  • Department of Cardiology, Bellvitge University Hospital, and Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), CIBERCV, L'Hospitalet de Llobregat, Spain.

Förderung

  • NHLBI NIH HHS
  • University of Ottawa
  • Heart and Stroke Foundation of Canada

Zitieren

APA

Barnes, G. D., Ageno, W., Castellucci, L. A., Chiasakul, T., Eslick, R., Ferreiro, J. L., Gailani, D., Gorog, D. A., Lip, G. Y. H., Raffini, L., Rezende, S. M., Weitz, J. I., & Cuker, A. (2023). Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. Journal of Thrombosis and Haemostasis, 21(5), 1381-1384. https://doi.org/10.1016/j.jtha.2023.02.008

Vancouver

Barnes GD, Ageno W, Castellucci LA, Chiasakul T, Eslick R, Ferreiro JL, et al. Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. Journal of Thrombosis and Haemostasis. 2023;21(5):1381-1384. doi:10.1016/j.jtha.2023.02.008

BibTeX
@article{Barnes2023,
  author = {Barnes, Geoffrey D and Ageno, Walter and Castellucci, Lana A and Chiasakul, Thita and Eslick, Renee and Ferreiro, José L and Gailani, David and Gorog, Diana A and Lip, Gregory Y H and Raffini, Leslie and Rezende, Suely M and Weitz, Jeffrey I and Cuker, Adam},
  title = {Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {5},
  pages = {1381--1384},
  doi = {10.1016/j.jtha.2023.02.008}
}
Kostenlos starten →